| MEDEX | REBAX | MEDEX / REBAX | |
| Total Expense Ratio | 1.32 | 1.11 | 119% |
| Annual Report Gross Expense Ratio | 1.33 | 1.11 | 120% |
| Fund Existence | 18 years | 20 years | - |
| Gain YTD | 2.687 | 2.645 | 102% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.64B | 370M | 2,064% |
| Annual Yield % from dividends | 4.92 | 4.76 | 103% |
| Returns for 1 year | 9.83 | 9.80 | 100% |
| Returns for 3 years | 30.42 | 30.99 | 98% |
| Returns for 5 years | 12.17 | 11.61 | 105% |
| Returns for 10 years | 38.58 | 37.26 | 104% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BAHAX | 17.83 | 0.37 | +2.12% |
| Brown Advisory WMC Strat Eurp Eq Adv | |||
| FDVAX | 31.24 | 0.20 | +0.64% |
| Fidelity Advisor Diversified Intl A | |||
| LAFYX | 22.53 | 0.04 | +0.18% |
| Lord Abbett Affiliated I | |||
| SCCUX | 12.33 | N/A | N/A |
| Invesco Income Advantage U.S. Fund C | |||
| CCISX | 13.80 | -0.22 | -1.57% |
| Calamos International Small Cap Gr C | |||